Atlas Logo
Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease (KBASE)
Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease logo
BACK
Sample details

The KBASE is a longitudinal cohort study following individuals with a wide range of cognitive statuses (cognitively normal, mild cognitive impairment, and Alzheimer's disease dementia) to discover novel biomarkers for the early detection of Alzheimer's disease. A total of 591 individuals (365 cognitively normal, 139 mild cognitive impairment, and 87 Alzheimer's disease dementia older adults) aged 20 - 90 years old were recruited from 4 sites (2 university hospital and 2 public centres) in Seoul, South Korea and completed baseline assessment in 2014. Participants are followed annually with clinical and neuropsychological assessments, and biannually with full KBASE assessments, including neuroimaging and blood laboratory tests.

Study design
Cohort - clinical

Number of participants at first data collection

591 (participants)

Age at first data collection

20 - 90 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Control participants
Older and elderly people
People with mild and major neurocognitive disorders
Dataset details

Country

South Korea

Year of first data collection

2014

Primary Institutions

Seoul National University (서울대학교, SNU)

Links

kbase.kr/eng/main/index.php

gaaindata.org/partner/KBASE

Funders

Ministry of Science and Technology

Ongoing?
Yes

Data types collected

neuroImagingData
mentalHealthData
dataLinkage
Quantitative data collection
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Interview – face-to-face
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Secondary data
  • Self-report questionnaire – unspecified
  • Wearable devices
Qualitative data collection
  • None
Neuroimaging data collection
  • Magnetic Resonance Angiography (MRA)
  • Arterial Spin Labelling (ASL)
  • Functional magnetic resonance imaging (fMRI)
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
Linked or secondary data
  • Healthcare data
Features

Engagement

  • None
  • Keywords

    Alzheimer's disease (AD)
    Biological samples/biospecimens
    Cognitive assessments
    Dementia
    Memory
    Mild cognitive impairment (MCI)
    Neuroimaging
    Neuropsychological testing
    Personality
    Sleep

    Consortia and dataset groups

    Global Alzheimer’s Association Interactive Network (GAAIN)
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis